Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002230337 | SCV000546060 | pathogenic | Hereditary hemochromatosis | 2023-04-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu183Glyfs*60) in the HFE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HFE are known to be pathogenic (PMID: 27518069). This variant is present in population databases (rs765804978, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with HFE-related conditions. ClinVar contains an entry for this variant (Variation ID: 407079). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002489030 | SCV002785265 | likely pathogenic | Variegate porphyria; Microvascular complications of diabetes, susceptibility to, 7; Alzheimer disease type 1; Hemochromatosis type 1; TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; Familial porphyria cutanea tarda | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003126743 | SCV003801604 | likely pathogenic | Hemochromatosis type 1 | 2023-02-08 | criteria provided, single submitter | clinical testing |